Emergent Total Assets from 2010 to 2024
| EBS Stock | USD 5.02 0.16 3.09% |
Total Assets | First Reported 2004-12-31 | Previous Quarter 1.8 B | Current Value 1.8 B | Quarterly Volatility 955.1 M |
Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent main balance sheet or income statement drivers, such as Depreciation And Amortization of 158.9 M, Interest Expense of 45 M or Total Revenue of 1.4 B, as well as many exotic indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.018 or PTB Ratio of 0.18. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
Emergent | Total Assets |
Latest Emergent Biosolutions' Total Assets Growth Pattern
Below is the plot of the Total Assets of Emergent Biosolutions over the last few years. Total assets refers to the total amount of Emergent Biosolutions assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Emergent Biosolutions books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Emergent Biosolutions' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.17 B | 10 Years Trend |
|
Total Assets |
| Timeline |
Emergent Total Assets Regression Statistics
| Arithmetic Mean | 1,788,338,500 | |
| Geometric Mean | 1,164,616,307 | |
| Coefficient Of Variation | 70.86 | |
| Mean Deviation | 1,135,252,000 | |
| Median | 1,070,206,000 | |
| Standard Deviation | 1,267,191,409 | |
| Sample Variance | 1605774.1T | |
| Range | 3.8B | |
| R-Value | 0.97 | |
| Mean Square Error | 94438.7T | |
| R-Squared | 0.95 | |
| Slope | 275,506,895 | |
| Total Sum of Squares | 22480836.9T |
Emergent Total Assets History
Other Fundumenentals of Emergent Biosolutions
Emergent Biosolutions Total Assets component correlations
Click cells to compare fundamentals
About Emergent Biosolutions Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Emergent Biosolutions income statement, its balance sheet, and the statement of cash flows. Emergent Biosolutions investors use historical funamental indicators, such as Emergent Biosolutions's Total Assets, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may use each financial statement separately, they are all related. The changes in Emergent Biosolutions's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Emergent Biosolutions's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Emergent Biosolutions Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Emergent Biosolutions. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 3.6 B | 3.8 B | |
| Intangibles To Total Assets | 0.31 | 0.29 |
Pair Trading with Emergent Biosolutions
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.Moving together with Emergent Stock
| 0.74 | PFE | Pfizer Inc Buyout Trend | PairCorr |
Moving against Emergent Stock
| 0.69 | CVS | CVS Health Corp | PairCorr |
| 0.47 | FBRX | Forte Biosciences | PairCorr |
| 0.46 | ABVC | ABVC Biopharma Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Emergent Biosolutions Correlation against competitors. For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Emergent Stock analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Earnings Share (10.97) | Revenue Per Share 22.928 | Quarterly Revenue Growth 0.828 | Return On Assets (0) |
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.